Please assess the completion status of the following clinical trial:

Trial Title: International Randomized Study of the TransMedics Organ Care System (OCS Lung) for Lung Preservation and Transplantation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Registered primary double-lung transplant candidate~* Age \> or equal to 18~* Signed: 1) written informed consent document and 2) authorization to use and disclose protected health information~Exclusion Criteria:~* Prior solid organ or bone marrow transplant~* Single lung recipient~* Multiple organ transplant recipient~* Chronic use of hemodialysis or diagnosis of chronic renal insufficiency

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OCS Lung (Treatment Group) (Type: EXPERIMENTAL): The OCS Lung, which is a portable, integrated platform designed to maintain adult donor lungs in a normothermic state through continuous normothermic perfusion and ventilation, will be used to preserve and transport donor lungs.
- Cold flush and storage (Control Group) (Type: ACTIVE_COMPARATOR): Donor lungs will be preserved using cold flush and storage (control group)

Based on this trial design, predict the completion outcome and termination type (if applicable).